Page
%P
-
Article
Open AccessMetastatic breast cancer: prolongation of survival in routine care is restricted to hormone-receptor- and Her2-positive tumors
18,000 women die due to metastatic breast cancer in Germany per year. Median survival is 20–28 months after diagnosis. The question we wanted to answer was whether survival has improved in routine care? For th...
-
Article
Open AccessAdherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice
Due to the increase of oral agents nonadherence is an emerging challenge in cancer care. We evaluated how well different assessments match and how adherence could be measured in routine care. For this purpose ...